Essential neurorehabilitation in the aftermath of COVID-19

6 July, 2020 | Posted in: ,

The impact of coronavirus on our health service has been highly documented, but with the first wave passed, the burden has not lifted, but altered, in the form of rehabilitation. Earlier this week, we highlighted an article in Reuters which has since been echoed in multiple publications – the long-term implications of COVID-19 on a […]

Continue Reading »

World MS Day 2020

30 May, 2020 | Posted in:

World MS is officially marked on 30th May. It brings the global MS community together to share stories, raise awareness and campaign with everyone affected by multiple sclerosis (MS). World MS Day activities take place throughout the month of May and in early June. The campaign offers flexibility for individuals and organisations to achieve a […]

Continue Reading »

Fampyra approved in Scotland

17 April, 2020 | Posted in:

The Scottish Medicines Consortium (SMC) have approved ‘Fampyra’ for use by people living with multiple sclerosis (MS) in Scotland. Around 2 in 3 people with MS will develop walking difficulties and the drug, fampridine, improves walking ability in those responsive to it; around 1 in 3 people who try it (Biogen). Developed by Biogen Idec, […]

Continue Reading »

Paper published on disease-modifying therapies for MS and COVID-19

17 April, 2020 | Posted in: , ,

Professor Gavin Giovannoni has published a commentary paper on ‘The COVID-19 pandemic and the use of MS disease-modifying therapies’ in Elsevier.  During the coronavirus pandemic, one of the biggest areas of discussion and concern amongst the multiple sclerosis (MS) community has been around disease-modifying therapies. From what to begin and how, to safe monitoring, to […]

Continue Reading »

MS Academy in Neurodigest

17 April, 2020 | Posted in: ,

Neurodigest have just published a piece on how unique education creates clinical leaders and transforms services.  Part of Neurology Academy, whose vision is to deliver uniquely practical education to produce specialist clinical leaders and transform local healthcare, MS Academy’s variety of bespoke courses follows the hugely successful model established 18 years ago for Parkinson’s. Fully […]

Continue Reading »

New MS prevalence data and smoking statistics

17 March, 2020 | Posted in:

A new briefing from Public Health England has issued new prevalence data on MS and links with smoking. Seeking insight into the characteristics of people with MS, the briefing was developed in collaboration with the MS Society and using the THIN dataset.   The evidence, which was gathered over an eight year period from financial […]

Continue Reading »

New roadmap produced to help doctors become medical cannabis prescribers

4 February, 2020 | Posted in:

Last week, the Medical Cannabis Clinicians Society published a ‘roadmap’ for doctors who want to become medical cannabis prescribers to support patients living with chronic health conditions.  The Society’s expert committee has brought together information from the government, the NHS, NICE, Royal Colleges, licensed producers of medical cannabis products and training providers into one place […]

Continue Reading »